Oculis Holding AG (OCS)

27.50 -1.11 (-3.88%) USD  |  NASDAQ  |  Mar 03, 10:32
More

Oculis EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for OCS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
EvoNext Holdings SA Upgrade
Kuros Biosciences Ltd. Upgrade
Basilea Pharmaceutica AG Upgrade
Santhera Pharmaceuticals Holding AG Upgrade
BeOne Medicines Ltd. Upgrade